Company intelligence / Profile preview

Ascertain Biotech

Northbrook, Illinois, United Stateslinkedin.com ↗

Ownership: Private
Employees: ~5
Development stage: Preclinical

Overview

Ascertain Biotech is an active company providing artificial intelligence-driven solutions aimed at improving outcomes in spine surgery, plastic surgery, and depression management. The company positions itself as the first AI healthcare firm addressing unaddressed problems in these areas. No specific drug or device clinical trial results are reported; the focus is on digital health platforms.

Therapeutic areas: OtherPsychiatryNeurology
Modalities: Device (AI-driven healthcare solutions)Non-pharmacological therapy (AI-based clinical decision support and management tools)
Industry: Digital Health Medical Devices

Drug pipeline

1 asset

HBS-102

Pre-clinical

Indications: Depression

Beyond the preview

Go deeper on Ascertain Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ascertain Biotech.

Explore the full profile